Correlation Between Iradimed and Telesis Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iradimed and Telesis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iradimed and Telesis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iradimed Co and Telesis Bio, you can compare the effects of market volatilities on Iradimed and Telesis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iradimed with a short position of Telesis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iradimed and Telesis Bio.

Diversification Opportunities for Iradimed and Telesis Bio

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Iradimed and Telesis is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Iradimed Co and Telesis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telesis Bio and Iradimed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iradimed Co are associated (or correlated) with Telesis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telesis Bio has no effect on the direction of Iradimed i.e., Iradimed and Telesis Bio go up and down completely randomly.

Pair Corralation between Iradimed and Telesis Bio

Given the investment horizon of 90 days Iradimed is expected to generate 12.98 times less return on investment than Telesis Bio. But when comparing it to its historical volatility, Iradimed Co is 14.43 times less risky than Telesis Bio. It trades about 0.07 of its potential returns per unit of risk. Telesis Bio is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  410.00  in Telesis Bio on July 26, 2024 and sell it today you would lose (112.00) from holding Telesis Bio or give up 27.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy78.13%
ValuesDaily Returns

Iradimed Co  vs.  Telesis Bio

 Performance 
       Timeline  
Iradimed 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Iradimed Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile primary indicators, Iradimed may actually be approaching a critical reversion point that can send shares even higher in November 2024.
Telesis Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Modest
Over the last 90 days Telesis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak forward indicators, Telesis Bio displayed solid returns over the last few months and may actually be approaching a breakup point.

Iradimed and Telesis Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iradimed and Telesis Bio

The main advantage of trading using opposite Iradimed and Telesis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iradimed position performs unexpectedly, Telesis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will offset losses from the drop in Telesis Bio's long position.
The idea behind Iradimed Co and Telesis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences